| Quarter | Score |
|---|---|
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.3 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 36.1 |
| 2023-Q3 | 48.8 |
| 2023-Q4 | 42.7 |
| 2024-Q1 | 62.6 |
| 2024-Q2 | 67.9 |
| 2024-Q3 | 57.4 |
| 2024-Q4 | 57.4 |
| 2025-Q1 | 58.5 |
| 2025-Q2 | 61.8 |
| 2025-Q3 | 61.7 |
| 2025-Q4 | 61.6 |
| 2026-Q1 | 78.8 |
| 2026-Q2 | 74.4 |
Stable institutional holding; maintain existing positions
No price reference available to measure drift vs fund cost basis
2 of 18 tracked funds hold ERJ. Avg conviction: 0.2%. Net holding. First tracked at $47.36.
Current price unavailable — check back later
Oaktree Capital has 0.4% in this stock
Too early to measure — check back next quarter
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oaktree Capital | 0.4% | Reduce |
| Citadel Advisors | 0.0% | Add |